Up to 100 biomarkers. One sample. Minutes. From bench to bedside.
MX-104 available now for research use. MX-200 expected Q1 2027. DX-100 clinical platform in development.
IRIS Kinetics was founded in 2020 around an optical biosensor invented in Prof. M. Selim Ünlü’s lab at Boston University.
He is the company’s founder, CTO and Executive Chairman, and a Distinguished Professor at Boston University. See his research
Label-free binding kinetics on the MX-200, designed to read up to 100 biomarkers in a run. Coming Q1 2027.
The volume the DX-100 cartridge is built around. The chip inside it is the same one running in labs today.
Answers in about ten minutes on the DX-100, which is in development.
sensor sees.
Each probe spot brightens as bound material accumulates on it. Traced over time, every spot gives its own binding curve.
About ten minutes from sample to result, at the point of care.
At the concentrations that matter, from a single drop of blood.
Up to 100 markers from one sample, read together.
A single-use cartridge with the chip inside.
Over four logs, enabled by kinetic precision.
